Adding Belimumab Improves Renal Outcome in Lupus Nephritis

THURSDAY, Sept. 17, 2020 -- The addition of belimumab versus placebo to standard therapy increases the likelihood of a primary efficacy renal response in patients with active lupus nephritis, according to a study published in the Sept. 17 issue of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news